title: CDK4/6 inhibitors in luminal breast cancer.
authors.affiliation: Departments of Surgery, Breast Health Center, Comprehensive Cancer Center, Medical University of Vienna, A-1090 Vienna, Austria. Electronic address: michael.gnant@meduniwien.ac.at.
authors.forename: Michael
authors.initials: M
authors.lastname: Gnant
authors.affiliation: Internal Medicine I, Breast Health Center, Comprehensive Cancer Center, Medical University of Vienna, A-1090 Vienna, Austria.
authors.forename: Guenther G
authors.initials: GG
authors.lastname: Steger
authors.affiliation: Internal Medicine I, Breast Health Center, Comprehensive Cancer Center, Medical University of Vienna, A-1090 Vienna, Austria.
authors.forename: Rupert
authors.initials: R
authors.lastname: Bartsch
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000188:drug therapy*; D051358:Cyclin-Dependent Kinase 4 / Q000037:antagonists & inhibitors*; D051361:Cyclin-Dependent Kinase 6 / Q000037:antagonists & inhibitors*; D005260:Female; D006801:Humans; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis*; D011960:Receptors, Estrogen / Q000032:analysis*
chemical_list: D014408:Biomarkers, Tumor; D051358:Cyclin-Dependent Kinase 4; D051361:Cyclin-Dependent Kinase 6; D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; C508053:ERBB2 protein, human; C495900:CDK4 protein, human; C495911:CDK6 protein, human